AI Article Synopsis

  • The study aims to develop a practical method for identifying high-risk patients with sepsis, particularly those who may experience sepsis-associated delirium (SAD), which can worsen prognoses.
  • By analyzing data from over 28,000 ICU patients, researchers found that those with a lower Braden score (≤ 15) had significantly higher rates of delirium and increased mortality compared to those with higher scores.
  • The study concludes that the Braden score is a useful and straightforward tool for early detection of patients facing a higher risk of negative outcomes in sepsis cases.

Article Abstract

Aims And Objectives: To provide a viable tool for the early clinical identification of high-risk populations in patients with sepsis.

Background: Sepsis-associated delirium (SAD) has the potential to significantly impact the short- and long-term prognosis of patients. However, accurately predicting and effectively managing SAD remains a significant challenge.

Methods: This study employed a retrospective analysis of adult sepsis patients admitted to the intensive care unit (ICU) for the first time. Patients were divided into two groups based on their initial Braden score upon admission to the ICU: a high-risk group (≤ 15 points) and a low-risk group (> 15 points). The relationship between Braden score and delirium was assessed using logistic regression and restricted cubic splines, while restricted mean survival time was employed to analyse the relationship between Braden scores and patients' 90- and 180-day mortality.

Results: Of the 28,312 patients included in the study, those in the high-risk group exhibited a significantly elevated risk of delirium (44.8% vs. 29.7%) and higher 90-day (28.7% vs. 19.4%) and 180-day (33.2% vs. 24.1%) mortality rates (all p < 0.001). After adjusting for confounding variables, logistic regression demonstrated that the risk of delirium was 1.54 times higher in the high-risk group (95% CI = 1.45-1.64, p < 0.001). Following propensity score matching, the difference in survival was statistically significant at both time points, with the high-risk group having a reduced survival rate of 7.50 days (95% CI = -8.24, -6.75; p < 0.001) and 15.74 days (95% CI = -17.40, -14.08; p < 0.001) at 90 days and 180 days, respectively.

Conclusions: The Braden score is a simple and effective tool for the early identification of patients at increased risk of adverse outcomes in sepsis.

Design: Retrospective study.

Relevance To Clinical Practice: The Braden score can be employed by clinical nurses for the purpose of early identification of poor prognostic risk in patients with sepsis.

Reporting Method: This study was conducted according to the Strengthening Research in Observational Studies in Epidemiology (STROBE) guidelines.

Patient Or Public Contribution: Patients were involved in the sample of the study.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocn.17476DOI Listing

Publication Analysis

Top Keywords

braden score
12
risk delirium
8
high-risk group
8
relationship braden
8
patients
5
assessing risk
4
delirium
4
delirium death
4
death sepsis
4
braden
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!